REN-27403-59265 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-06
Registered in v-safe
2021-01-06
Dose 1 — Pfizer-BioNTech
2021-01-06
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain, Itching · Headache

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches

Adult check-in
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-21
Survey response — day 14, dose 1
MedDRA: Oropharyngeal pain, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Sore throat, fever

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-27
Dose 2 — Pfizer-BioNTech
2021-02-17
Survey response — day 21, dose 2
MedDRA: Pain — Feeling: Good · Be unable to work, Be unable to do your normal daily activities

Free text: Body achs

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-24
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-03
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-10
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-28
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-28
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-29
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-01-27
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-09-29
Survey response — 12 months, dose 3
MedDRA: Post-acute COVID-19 syndrome, Pulmonary hypertension — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Pulmonary hypertension from long covid

MedDRA releases: 2024-11 · check-in free text available
2022-09-29
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-09-30
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-06	Pfizer-BioNTech
2	2021-01-27	Pfizer-BioNTech
3	2021-09-29	Pfizer-BioNTech	Flu

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 2 — day 14, dose 1

2021-01-21

Symptoms: Sore throat, fever

Release 4 — day 21, dose 2

2021-02-17

Symptoms: Body achs

Release 12 — 12 months, dose 3

2022-09-29

Symptoms: Pulmonary hypertension from long covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Oropharyngeal pain	✓	✓	✓
SD	Pain	✓	✓	✓
SD	Post-acute COVID-19 syndrome	·	·	✓
SD	Pulmonary hypertension	·	·	✓
SD	Pyrexia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release